Education
About Us
Working with TipRanks
Follow Us
Encompass Health (EHC)
NYSE:EHC
EHC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$78.53 - $104.55
Previous CloseN/A
Volume95.02K
Average Volume (3M)817.47K
Market Cap
$10.42B
Enterprise Value$12.78B
Total Cash (Recent Filing)$116.80M
Total Debt (Recent Filing)$1.66B
Price to Earnings (P/E)23.1
Beta0.56
Next Earnings
Apr 24, 2025EPS Estimate
1.19Last Dividend Ex-Date
Apr 01, 2025Dividend Yield0.62%
Share Statistics
EPS (TTM)4.46
Shares Outstanding100,967,060
10 Day Avg. Volume930,979
30 Day Avg. Volume817,473
Financial Highlights & Ratios
PEG Ratio0.81
Price to Book (P/B)N/A
Price to Sales (P/S)1.82
Price to Cash Flow (P/CF)8.80
P/FCF Ratio8.60
Enterprise Value/Market Cap1.23
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.17
Enterprise Value/Ebitda10.87
Forecast
1Y Price Target
$117.00Price Target Upside14.52% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
---
Encompass Health News
PremiumCompany Announcements
Encompass Health Approves Executive Compensation Increases
PremiumCompany Announcements
Encompass Health: Strong Q4 2024 Performance and Positive 2025 Outlook
PremiumCompany Announcements
Encompass Health’s Earnings Call Highlights Robust Growth
---
Bulls Say, Bears Say
Bulls Say
Earnings PerformanceEHC reported results that exceeded consensus EPS estimates, driven by strong same-store discharge growth.
Expansion StrategyEHC plans to expand with new facilities and additional beds, indicating growth and investment in infrastructure.
Market PositionEHC benefits from idiosyncratic Medicare Advantage tailwinds and limited Medicaid/Health Insurance Exchange exposure.
Bears Say
Forecast HeadwindsSeveral non-recurring items and headwinds, such as favorable reserves adjustments and increased start-up costs, are affecting the forecast.
Non-Recurring ItemsThe earnings outlook remains skewed to the upside with a reasonable valuation near 10x the 2026 EBITDA forecast.
---
Ownership Overview
1.48% Insiders
31.56% Mutual Funds
21.44% Other Institutional Investors
22.52% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EHC FAQ
What was Encompass Health’s price range in the past 12 months?
Encompass Health lowest stock price was $78.53 and its highest was $104.55 in the past 12 months.
What is Encompass Health’s market cap?
Encompass Health’s market cap is $10.42B.
When is Encompass Health’s upcoming earnings report date?
Encompass Health’s upcoming earnings report date is Apr 24, 2025 which is in 11 days.
How were Encompass Health’s earnings last quarter?
Encompass Health released its earnings results on Feb 06, 2025. The company reported $1.17 earnings per share for the quarter, beating the consensus estimate of $1.025 by $0.145.
Is Encompass Health overvalued?
According to Wall Street analysts Encompass Health’s price is currently Undervalued.
Does Encompass Health pay dividends?
Encompass Health pays a Thriceyearly dividend of $0.66 which represents an annual dividend yield of 0.62%. See more information on Encompass Health dividends here
What is Encompass Health’s EPS estimate?
Encompass Health’s EPS estimate is 1.19.
How many shares outstanding does Encompass Health have?
Encompass Health has 100,967,060 shares outstanding.
What happened to Encompass Health’s price movement after its last earnings report?
Encompass Health reported an EPS of $1.17 in its last earnings report, beating expectations of $1.025. Following the earnings report the stock price went up 1.28%.
Which hedge fund is a major shareholder of Encompass Health?
Currently, no hedge funds are holding shares in EHC
---
Encompass Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$117.00 (14.52% Upside)
$117.00 (14.52% Upside)
Blogger Sentiment
Bullish
EHC Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 507.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $495.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 3.2%
Last 30 Days ▲ 3.1%
Last 30 Days ▲ 3.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
26.08%
12-Months-Change
Fundamentals
Return on Equity
24.52%
Trailing 12-Months
Asset Growth
7.08%
Trailing 12-Months
Company Description
Encompass Health
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
---
EHC Company Deck
---
EHC Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong financial performance with significant growth in revenue, EBITDA, and Medicare Advantage discharges. However, challenges such as increased group medical costs and uncertain provider tax benefits present headwinds. The overall sentiment leans towards positive due to the robust financial metrics and strategic growth initiatives.Read More>---
EHC Stock 12 Month Forecast
Average Price Target
$117.00
▲(14.52% Upside)
Technical Analysis
Best Analysts Covering EHC
1 Year
1 Year Success Rate
29/31 ratings generated profit
1 Year Average Return
+27.13%
reiterated a buy rating 2 months ago
Copying David S Macdonald's trades and holding each position for 1 Year would result in 93.55% of your transactions generating a profit, with an average return of +27.13% per trade.
---